Kim Tae-ri’s Breakfast Secret: The 3 Simple Foods Behind Her Radiant Skin
Actress Kim Tae-ri, celebrated for her role in the film The Handmaiden and her seemingly ageless, blemish-free complexion, recently shared the simple...
Search results for "clinical trial"
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite hormone and chemotherapy.
The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack
New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds;...
The Superfood of the Sea: Why Seaweed is a Nutritional Powerhouse
A staple of the Korean table, seaweed appears in everything from savory soups to stir-fried kelp stems.
Beyond the Hype: Does Your Daily Collagen Supplement Actually Work?
Research suggests that while regular collagen supplementation can enhance skin health, consumers should maintain...
Meditative Breathing and Men’s Health: Can Deep Breathing Extend Sexual Duration?
Recent clinical research suggests that a simple adjustment to respiratory habits may offer a long-term solution for men...
Beyond the X-Ray: South Korean Researchers Develop AI to Pinpoint Precise Knee Osteoarthritis Wear
A South Korean research team has developed a breakthrough imaging indicator that utilizes AI deep learning to identify...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium
SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...